Tests that provide molecular details on a specific tumor aren’t routinely done for pediatric brain tumors, but research suggests the extra step could change a child’s therapy.
Michigan-led research presents a new way of uncovering predictive biomarkers when data from large randomized trials aren’t available.
A genetic mutation makes a glioma subtype resistant to radiation, but a new study finds a potential way around it using currently available drugs.
An analysis of several hundred DIPG and related tumors, including Chad Carr’s, finds an overlooked key factor in determining prognosis for the aggressive childhood brain cancer.
Donated tumor tissue from a 5-year-old brain cancer patient uncovers the key and early role of a less-understood genetic mutation in the cancer’s fatal course.
How a new research initiative is empowering U-M physician-scientists to fight DIPG, one of the deadliest brain cancers, in innovative ways.